Skip to main content
Log in

Effects of Melaxen and Valdoxan on Superoxide Dismutase and Catalase Activities in Experimental Hyperthyroidism

  • Published:
Pharmaceutical Chemistry Journal Aims and scope

The effects of Melaxen and Valdoxan on measures of biochemiluminescence (BCL) were studied on the background of the development of experimental hyperthyroidism in terms of the light sum of chemiluminescence (S) and the maximum peak intensity (I max), which characterize the intensity of free radical processes, and the tangent of the kinetic curve slope (tgα2), which reflects total antioxidant activity; effects on superoxide dismutase and catalase activities in tissues and serum were also studied. Increases in these measures due to oxidative stress in experimental hyperthyroidism were found to normalize in response to these agents.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. P. Venditti, M. Balestrieri, S. D. Meo, et al., J. Endocrinol., 155, 151–157 (1997).

    Article  PubMed  CAS  Google Scholar 

  2. B. Pereira, R. Cosa, D. A. Safi, et al., J. Endocrinol., 140, 73–77 (1994).

    Article  PubMed  CAS  Google Scholar 

  3. R. J. Reiter, D. X. Tan, C. Osuna, et al., J. Biomed. Sci., 7, 444–458 (2000).

    Article  PubMed  CAS  Google Scholar 

  4. V. Srinivasan, Ph. D. R. Zakaria, Z. Othman, et al., J. Neuropsych. Clin. Neurosci., 24(3), 290–308 (2012).

    Article  CAS  Google Scholar 

  5. V. Fernandez, K. Simizu, S. B. M. Barros, et al., Endocrinology, 129(1), 85–91 (1991).

    Article  PubMed  CAS  Google Scholar 

  6. E. I. Kuz’mina, A. S. Nelyubin, and M. K. Shchennikova, Interuniversity Collection: The Biochemistry and Biophysics of Microorganisms [in Russian], Gorky (1983), pp. 179–183.

  7. M. A. Korolyuk, L. I. Ivanova, I. G. Maiorova, et al., Lab. Delo, No. 1, 16–19 (1988).

  8. E. Lloyd and U. Lederman, Handbook of Applied Statistics [Russian translation], Moscow (1990).

  9. E. J. Sanchez-Barcelo, C. M. Martinez-Campa, M. D. Mediavilla, et al., Rec. Patents Endocrine, Metabol. Immun. Drug Discov., 1(2), 142–151 (2007).

    Article  CAS  Google Scholar 

  10. O. A. Safonova, T. N. Popova, and L. Saidi, Vopr. Biol. Med. Farm. Khim., No. 7, 33–36 (2011).

  11. O. Seymen, A. Seven, G. Candan, Acta Med. Okayma, 51(3), 129–133 (1997).

    CAS  Google Scholar 

  12. É. B. Arushanyan, Éksperim. Klin. Farmakol., 74(7), 41–45 (2011).

    CAS  Google Scholar 

  13. R. J. Reiter, D. X. Tan, L. C. Manchester, et al., Ann. N. Y. Acad. Sci., 959, 238–250 (2002).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 47, No. 11, pp. 7 – 10, November, 2013.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gorbenko, M.V., Popova, T.N., Shul’gin, K.K. et al. Effects of Melaxen and Valdoxan on Superoxide Dismutase and Catalase Activities in Experimental Hyperthyroidism. Pharm Chem J 47, 577–580 (2014). https://doi.org/10.1007/s11094-014-1010-1

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-014-1010-1

Keywords

Navigation